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Abstract
Background: During pregnancy, nutritional requirements increase and if not met, pregnancy-related complications
may manifest. To prevent these undesirable outcomes, the World Health Organization recommends daily oral iron
and folic acid (IFA) supplementation as part of antenatal care. Despite this recommendation, the use of IFA
supplements is still very low in several developing countries. Additionally, no prior information exists regarding the
level of consumption of IFA in Eswatini. Thus, this study aimed to determine the prevalence of consumption of IFA
supplements and to identify factors associated with the consumption of IFA supplements among pregnant women
in Eswatini.
Methods: A cross-sectional questionnaire survey was conducted among 330 pregnant women aged ≥ 18 years in
their third trimester in Eswatini. Participants were recruited from eight purposively selected healthcare facilities from
July 2019 to October 2019. Good consumption was defined as consuming all or almost all IFA supplements
throughout pregnancy.
Results: During the first trimester, 10.3 % of the participants consumed all or almost all IFA supplements. In the
second and third trimesters, those who consumed all or almost all supplements were 37 and 39.7 %, respectively,
for iron and 37.6 and 40.9 %, respectively, for folic acid. Barriers, including side effects, forgetfulness, safe previous
pregnancies without IFA, others’ advice against consumption, IFA stock-outs, inability to meet transport costs, and
inadequate supply of IFA tablets, contribute to low consumption of IFA. Multivariate logistic regression models
showed that the barriers were inversely associated with good consumption of IFA supplements. Better knowledge
and attitude toward IFA and older maternal age were positively associated with good consumption of IFA
supplements.
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Conclusions: Low consumption of IFA supplements in overall pregnancy is mainly owing to the late antenatal care
attendance. Strategies such as establishing a preconception care unit and school-based provision of IFA may be helpful. It is
evident that most women still lack knowledge, and some have negative attitudes about IFA supplements. Health education
to raise awareness and emphasize the importance of starting antenatal care early as well as consuming supplements on
time should be revisited and intensified. Multiple strategies such as including community health care workers for distributing
IFA supplements, discussing with clients about the measures to reduce forgetfulness, advising ways to prevent and manage
the side effects, providing subsidies to cover transport costs, and ensuring adequate supply of IFA supplements in facilities
may need to be employed to reduce the identified barriers.
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Background
Nutritional requirements increase during pregnancy for
supporting fetal growth and development as well as for
maternal metabolism and tissue development specific to
reproduction [1]. The recommended dietary allowance
for iron and folic acid (IFA) for non-pregnant women is
18 mg and 400 µg [2] when compared with 27 mg and
600 µg per day for pregnant women [3], respectively. If
the required increase in dietary allowance is not met,
numerous undesirable conditions may manifest. Folate
deficiencies have been linked to the development of
neural defects in infants [4], and iron deficiencies have
been linked to anemia and other conditions.
The average prevalence of anemia among pregnant
women in developing countries is 56 %, which is signifi-
cantly higher than that of 18 % in developed countries.
In Africa, the prevalence of anemia in pregnant women
is 48.2 % [5]. In Eswatini (a country in Southern Africa),
31 % of pregnant women fall under the classification of
maternal anemia [6], although the possible reasons for
the lower prevalence in Eswatini when compared with
other developing countries have not been studied.
Anemia is one of the major causes of pregnancy compli-
cations, leading to adverse maternal and perinatal out-
comes, including maternal and perinatal mortalities [7].
Anemia in pregnancy is highly associated with the risk
of miscarriages, stillbirths, prematurity, and low birth
weight [8]. It is estimated that 40 % of women in Eswa-
tini are likely to be anemic, which may be owing to in-
sufficient iron [9]. It is also estimated that 300,000
babies are born each year with neural tube defects glo-
bally, and 15–20 % of all births are low birth weight. The
2014 Swaziland Multiple Indicator Cluster Survey indi-
cated that 8 % of infants had low birth weight [10]. To
prevent and cure these outcomes, the World Health
Organization (WHO) strongly recommends daily oral
supplementation of IFA as part of antenatal care (ANC).
Studies conducted in different countries have shown that
the use of IFA early and during one’s pregnancy can re-
duce undesirable pregnancy outcomes [11–13]. In Eswa-
tini, the ANC package, which includes the provision of
IFA, has been made accessible and affordable to every
pregnant woman.
Despite the WHO recommendation, the use of IFA is
still low in some developing countries. Adherence to
iron supplementation across 22 Sub-Saharan African
countries was 28.7 %, with some countries having low
adherence, such as 1.4 % in Burundi [14]. Another study
in Northern Tanzania revealed that the prenatal intake
of folic acid and iron supplements by pregnant women
was 17.2 and 22.3 %, respectively [15]. Nonetheless, the
consumption of IFA was reported to be 93 % in South
Africa [16]. To the best of our knowledge, there is no
prior study on the consumption of IFA supplements
among pregnant women in Eswatini.
The factors associated with poor consumption in
countries such as Ethiopia and Egypt include lack of IFA
supplements owing to not getting enough supplements
to last until the next visit, forgetfulness, side effects of
oral medications, little knowledge about the importance
of supplements, and poor knowledge of anemia in preg-
nancy [8, 17]. In Eswatini, the problem of medication
stock-outs is also common. At some point, the country’s
local daily newspaper published that the country had
run out of essential drugs for pregnant women [18].
According to several studies, the following factors are
associated with good IFA consumption: more ANC
visits, early ANC booking, counseling and education on
IFA supplements, higher levels of education, diagnosis of
anemia in a previous ANC visit, exposure to mass media,
and presence of husbands during ANC visit [19–22].
Poor consumption arises not only because of the client’s
behaviors but also because of factors outside the client’s
control [23]. Such factors may include inadequate sup-
port from significant others and/or families and insuffi-
cient service delivery. Other client factors may include
frustrations about the number and frequency of the pills,
fear of macrosomia, etc. [24]. Limited information has
been gathered regarding the level of consumption of IFA
and related factors in Eswatini. Thus, this makes such a
study a necessity. This study aimed to determine the
consumption of IFA supplements, to explore IFA-related
barriers, knowledge, and attitude, and to determine the
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factors associated with the consumption of IFA supple-
ments among pregnant women in Eswatini.
Methods
Setting
The study was conducted in eight health care facilities that
were selected to represent the four regions of Eswatini;
each region was represented by two facilities. The facilities
were Mbabane Government Hospital and Lobamba Clinic
in the Hhohho region, Raleigh Fitkin Memorial Hospital
and Family Life Association of Swaziland in the Manzini
region, Sithobela Health Centre (Maternity unit) and
Sithobela Public Health Unit in the Lubombo region, and
Hlathikhulu Public Health Unit and Hlathikhulu Hospital
(maternity unit) in the Shiselweni region. The eight health
facilities were selected purposively, as these institutions
provide ANC services and have high volumes of clients in
the regions.
Study design and participants
This study used a cross-sectional questionnaire survey
design. The inclusion criteria were pregnant women
aged ≥ 18 years, residing in Eswatini, in their third tri-
mester, and visiting for a subsequent ANC at the eight
selected health facilities. Participants < 18 years were not
included because they needed parental consent to par-
ticipate. We selected third-trimester pregnant women
because we were interested in comparing IFA consump-
tion across different trimesters. It seems to be easier for
third-trimester pregnant women to recall their IFA con-
sumption than postpartum women. Besides, a high use
rate of any antenatal care (97.3 %) was reported in Eswa-
tini [25]. Therefore, we expected a high coverage rate of
antenatal care among third-trimester pregnant women.
During the period from July 2019 to October 2019, 330
women were invited to participate in the study; they all
agreed to participate.
Ethics approval and consent to participate
This study was approved by the National Health Re-
search Review Board, Ministry of Health, in Eswatini
(SRH139/2019). All procedures performed in studies in-
volving human participants were in accordance with the
1964 Helsinki declaration and its later amendments or
comparable ethical standards. Verbal and written in-
formed consents were obtained from all participants.
Sample size determination and sampling procedure
The sample size was determined using Cochran’s Sample
Size Formula following these assumptions: 95 % signifi-
cance level, 5 % margin of error, consumption of supple-
ments from a previous survey being 70 % according to
the last Demographic and Health Survey conducted in
the country [9]. The calculated sample size provided a
total of 323 participants. Overall, 330 participants were
recruited over a period of 12 weeks, and each regional
sample size was proportionate to the estimated number
of ANC service users in the regions.
Data collection tool
A researcher-developed structured questionnaire was
used as the study tool. The tool was developed in Eng-
lish, later translated to Swazi, and back to English to en-
sure consistency. After developing the questionnaire
based on the literature review, two experts in the field of
maternal and child health from Eswatini, who were well
informed about the local context, reviewed the question-
naire and gave feedback. The tool was pre-tested at
Nhlambeni Clinic in the Manzini region to ensure that
pregnant women could understand the questions with-
out difficulty.
Variables measurement
The dependent variable, which was the consumption of
IFA, was categorized into two categories: good and poor.
Consumption of IFA was self-reported. Participants were
asked if they took the supplements received in each of
the three trimesters, and their responses were as follows:
took all/almost all, took more than half, took half, took
less than half, took a few, did not take, and not applic-
able (for participants who did not receive the supple-
ments). Consuming all or almost all was categorized as
good, and all the other response options were catego-
rized as poor in each trimester. For overall consumption,
participants were categorized as a good consumer if they
had good consumption in all three trimesters and as a
poor consumer if they had poor consumption in at least
one trimester. Independent variables included socio-
demographic characteristics (see Table 1 for the list of
variables), knowledge, attitude, partner’s support, and
barriers to IFA consumption. Partner’s support was mea-
sured using the question, “Do you receive support other
than money from your spouse/partner?” with a five-
point Likert scale (never, almost never, sometimes, al-
most always, every time).
Knowledge
Participants were asked to list three sources of iron and
three sources of folate, to state the correct timing of
starting IFA supplementation, and to list three benefits
of taking IFA supplements and three consequences of
not taking IFA supplements during pregnancy. An indi-
vidual’s responses to all the questions were added to
form a sum of knowledge scores. The score ranged from
0 to 13, with a higher score indicating better knowledge.
Internal consistency assessed using Cronbach’s alpha
was 0.82.
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Table 1 Participants’ characteristics based on overall consumption of iron and folic acid during pregnancy (N = 330)










18–24 139 (42.1) 3 (13.6) 136 (44.2) 6 (23.1) 133 (43.8)
25–30 101 (30.6) 10 (45.5) 91 (29.5) 10 (38.5) 91 (29.9)
≥ 31 90 (27.3) 9 (40.9) 81 (26.3) 10 (38.5) 80 (26.3)
Marital status
Single 167 (50.6) 8 (36.4) 159 (51.6) 10 (38.5) 157 (51.6)
Married but not living together 31 (9.4) 4 (18.2) 27 (8.8) 5 (19.2) 26 (8.6)
Married and living together 132 (40.0) 10 (45.5) 122 (39.6) 11 (42.3) 121 (39.8)
Education ** **
Primary and below 69 (20.9) 3 (13.6) 66 (21.4) 3 (11.5) 66 (21.7)
Secondary/high school 214 (64.8) 9 (40.9) 205 (66.6) 14 (53.8) 200 (65.8)
Tertiary 47 (14.2) 10 (45.5) 37 (12.0) 9 (34.6) 38 (12.5)
Religion
Christian 288 (87.3) 17 (77.3) 271 (88.0) 20 (76.9) 268 (88.2)
Other/non-religious 42 (12.7) 5 (22.7) 37 (12.0) 6 (23.1) 36 (11.8)
Income
Sufficient/very sufficient 130 (39.4) 13 (59.1) 117 (38.0) 12 (46.2) 118 (38.8)
Barely sufficient 71 (21.5) 4 (18.2) 67 (21.8) 6 (23.1) 65 (21.4)
Insufficient/very insufficient 129 (39.1) 5 (22.7) 124 (40.3) 8 (30.8) 121 (39.8)
Employment status *
Unemployed 234 (70.9) 9 (40.9) 225 (73.1) 14 (53.8) 220 (72.4)
Self employed 28 (8.5) 3 (13.6) 25 (8.1) 3 (11.5) 25 (8.2)
Employed 68 (20.6) 10 (45.5) 58 (18.8) 9 (34.6) 59 (19.4)
Place of residence
Urban 111 (33.6) 11 (50.0) 100 (32.5) 13 (50.0) 98 (32.2)
Rural 219 (66.4) 11 (50.0) 208 (67.5) 13 (50.0) 206 (67.8)
Gravidity
Primigravidity 114 (34.5) 9 (40.9) 105 (34.1) 11 (42.3) 103 (33.9)
Multi/Grand-multi gravidity 216 (65.5) 13 (59.1) 203 (65.9) 15 (57.7) 201 (66.1)
Gestational age at first ANC ** *
0–12 weeks 75 (22.7) 22 (100) 53 (17.2) 26 (100.0) 49 (16.1)
13–20 weeks 148 (44.8) 0 (0.0) 148 (48.1) 0 (0.0) 148 (48.7)
> 20 weeks 107 (32.4) 0 (0.0) 107 (34.7) 0 (0.0) 107 (35.2)
Having a supportive partner * *
Never/rarely 38 (11.5) 0 (0.0) 38 (12.3) 0 (0.0) 38 (12.5)
Sometimes 44 (13.3) 0 (0.0) 44 (14.3) 1 (3.8) 43 (14.1)
Always/almost always 248 (75.2) 22 (100.0) 226 (73.4) 25 (96.2) 223 (73.4)
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Attitudes 22.45(1.77) 19.07(3.11) 21.88(1.97) 19.07 (3.14)
Barriers 0.86 (1.05) 2.02 (1.08) 0.65 (0.69) 1.56 (1.22)
Knowledge 8.23 (3.27) 5.46 (2.81) 7.92 (3.12) 5.45 (2.81)
*indicates p values < 0.05 and ** indicates p values < 0.001 from chi-squared tests. ANC antenatal care; SD standard deviation
Mabuza et al. BMC Pregnancy and Childbirth          (2021) 21:469 Page 4 of 10
Attitudes
The attitudes were assessed using five items with a
Likert scale ranging from 1 to 5. Positive statements
were coded as 1 for strongly disagree and 5 for strongly
agree, and negative statements were reversely coded.
Items were then added to compute a sum of scores, with
a score ranging from 5 to 25, with a higher score indicat-
ing more positive attitudes toward IFA supplementation.
Internal consistency assessed using Cronbach’s alpha for
the attitude scale was 0.63.
Barriers
Participants were asked about their reasons for not hav-
ing a 100 % IFA consumption in their pregnancy. Differ-
ent reasons (10 reasons) for not consuming IFA were
listed, and these reasons were summed up to compute a
barrier score. The sum of scores ranged from 0 to 10,
with a higher score indicating more barriers for that
participant.
Data analyses
Data analyses were performed using SPSS version 24
(IBM Corp, Armonk, NY). Descriptive analysis was per-
formed to determine the prevalence of consumption of
IFA supplements. The distribution of variables was eval-
uated using means and their standard deviations for
continuous variables and proportions for categorical var-
iables. Multivariate logistic regression was used for de-
termining factors associated with the consumption of
IFA supplements, with the odds ratio (OR) as the meas-
ure of association. A two-sided p-value of < 0.05 was
considered statistically significant. For the selection of
the model, the Akaike information criterion (AIC) was
used, and the smallest AIC value represented a better fit-
ting model. We used a stepwise method and started
model building by entering all variables in the model,
then dropping one variable with the greatest p-value at
each step until all remaining variables were significant in
the model. Goodness of fit of the final model was exam-
ined by the Hosmer-Lemeshow test (p > 0.05).
Results
Participants’ characteristics
Of the 330 participants, a majority (42.1 %) aged 18–24
years, 50.6 % of the participants reported being single on
their marital status, 70.9 % were unemployed, and more
than half (66.4 %) resided in rural areas. Less than half
(34.5 %) of them were primigravidas. Only 22.7 % of the
participants started their ANC visits within their first tri-
mester, and 11.5 % of the participants reported that they
rarely or never received support from their partners
(Table 1).
Consumption of IFA supplements
The consumption of IFA supplements by pregnant
women is presented in Table 2. Good consumption was
when the respondent consumed all or almost all supple-
ments. During the first trimester, a few respondents
(10 %) consumed all or almost all IFA supplements. In
the second and third trimesters, those who consumed all
or almost all supplements were 37 and 39.7 %, respect-
ively, for iron and 37.6 and 40.9 %, respectively, for folic
acid, which shows an increase in the consumption of
both supplements from the first trimester. Women who
did not receive IFA supplements owing to a lack of ac-
cess were classified as not applicable (N/A). N/A in the
first trimester was mainly because participants did not
attend ANC in the first trimester; N/A in the second
and third trimesters was owing to a lack of supply, as
some facilities could not supply, and other participants
were also failing to attend ANC on the dates they were
booked for. When observing the overall consumption,
those respondents who consumed supplements as re-
quired (i.e., all or almost all) in all three trimesters, the
consumption was found to be good at 6.7 and 7.9 % for
iron and folic acid supplements, respectively.
Factors associated with the consumption of IFA
Barriers
There was a wide range of reasons for not consuming IFA
(Table 3). The most frequently cited reasons were side ef-
fects (27.5 %) and forgetfulness (25.2 %). The mean num-
ber of barriers reported was 1.49 (standard deviation (SD),
1.21). Women who reported good consumption of IFA re-
ported fewer barriers than women who reported poor
consumption (mean (SD): 0.86 (1.05) vs. 2.02 (1.08) for
iron; 0.65 (0.69) vs. 1.56 (1.22) for folate; both p < 0.001).
Knowledge
Participants had limited knowledge regarding IFA
(Table 4). When asked to name three food sources of
iron and folic acid, 61.5 % of respondents knew at least
two food sources of iron, while only 23.9 % of respon-
dents knew at least two food sources of folate. When
asked about the correct time to start taking IFA supple-
ments, only 35.8 % responded correctly. When asked
about the three benefits of taking the supplements, ap-
proximately 38.2 % of the respondents gave at least two
correct benefits. For the consequences of not taking IFA
supplements during pregnancy, only 21.6 % could give at
least two correct consequences. The mean knowledge
score was 5.65 (2.91). Women who reported good con-
sumption of IFA reported a higher knowledge than those
who reported poor consumption (mean (SD): 8.23 (3.27)
vs. 5.46 (2.81) for iron; 7.92 (3.12) vs. 5.45 (2.81) for fol-
ate; both p < 0.001).
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Attitude
Participants’ attitudes are presented in Table 5. The
mean attitude score was 19.29 (3.16). Over 40 % (43.1 %)
of women strongly agreed or agreed that “consuming
IFA could result in macrosomia”, and about 10 % (9.1 %)
of women strongly agreed or agreed that IFA should be
consumed only when there is a problem. Those women
who reported good consumption of IFA reported better
attitude than those who reported poor consumption
(mean (SD): 22.45 (1.77) vs. 19.07 (3.11) for iron; 21.88
(1.97) vs. 19.07 (3.14) for folate; both p < 0.001).
Bivariate analysis
The bivariate analysis of different variables with the
overall consumption status is presented in Table 1. The
status of iron consumption in all trimesters significantly
differed by age, education, and employment status. How-
ever, the status of folic acid consumption significantly
differed by education and gestational age at the first
ANC visit. Participants with good consumption of both
iron and folic acid started attending ANC within the first
12 weeks of their pregnancy. Out of the participants
who were classified as poor consumers of iron, only
17.2 % started attending ANC within the first 12 weeks
of their pregnancy. From the poor consumers of folic
acid, only 16.1 % started attending ANC within the first
12 weeks of their pregnancy. Participants with good con-
sumption of IFA were significantly more likely to report
that their partner was always or almost always support-
ive than participants with poor consumption (100 % vs.
73.4 % for iron; 96.2 % vs. 73.4 % for folic acid).
Multivariate analysis
The parsimonious logistic regression model is presented
in Table 6. The likelihood of consuming iron over the
three trimesters increased with age. Using the age of 18–
24 years as a comparison group, the odds of iron con-
sumption for those aged 25–30 years were 2.92 (95 %
confidence interval (CI): 0.71–12.06), and the odds for
the group aged above 30 years were 4.44 (95 % CI: 1.09–
18.10). An increase in the score of IFA knowledge was
associated with good iron consumption (adjusted OR
(AOR): 1.23, 95 % CI: 1.05–1.44), and similarly, an in-
crease in the score of attitudes was associated with good
iron consumption (AOR: 1.41, 95 % CI: 1.13–1.75). Hav-
ing barriers was a significant factor, and as the score of
barriers increased, the likelihood of consuming iron de-
creased (AOR: 0.53, 95 % CI: 0.29–0.97).
Table 6 illustrates that when a similar analysis was
performed for folic acid consumption in the three tri-
mesters, having a unit increase in the total score of
knowledge about IFA was significantly associated with
good consumption of folic acid supplements in the three
trimesters (AOR: 1.24, 95 % CI 1.07–1.43). Table 6 also
demonstrates that having barriers was a significant fac-
tor, and as the score of barriers increased, the likelihood
of consuming folic acid decreased (AOR: 0.51, 95 % CI:
0.31–0.89). Attitude lost its statistical significance when
knowledge and barriers were in the model for folic acid.
Table 2 Consumption of iron and folic acid supplements over the three trimesters of pregnancy (N = 330)
Consumption of iron Consumption of folic acid
1st trimester 2nd trimester 3rd trimester 1st trimester 2nd trimester 3rd trimester
All/almost all 34 (10.3) 122 (37.0) 131 (39.7) 34 (10.3) 124 (37.6) 135 (40.9)
More than half 15 (4.5) 67 (20.3) 67 (20.3) 14 (4.2) 57 (17.3) 69 (20.9)
Half 7 (2.1) 38 (11.5) 38 (11.5) 4 (1.2) 39 (11.8) 33 (10.0)
Less than half 7 (2.1) 32 (9.7) 36 (10.9) 10 (3.0) 32 (9.7) 33 (10.0)
Did not consume or consumed a few 6 (1.8) 23 (7.0) 40 (12.1) 9 (2.7) 31 (9.4) 43 (13.0)
N/A 261 (79.1) 48 (14.5) 18 (5.5) 259 (78.5) 47 (14.2) 17 (5.2)
N/A is not applicable, meaning women who cannot access iron and folic acid supplements. N/A refers to participants who did not attend antenatal care or did
not receive the supply in facilities owing to limited stock
Table 3 Participants’ reasons for not consuming iron and folic
acid supplements (N = 330)
Reasons n %
Long walking distance to health facility 27 8.2
Transport costs 40 12.1
Safe previous pregnancies without iron and folic acid
supplements
56 17.0
Advised by friends/relatives not to consume 54 16.4
Use of traditional medicine 34 10.3
Forgetfulness 83 25.2
Side effects 89 27.0
Inadequate supplya 34 10.3
Tablets were out of stock in facility 47 14.2
Dislike medication 27 8.2
Number of barriers; Mean (SD) 1.49
(1.21)
Number of barriers score range: 0–10. A high total score indicates more
barriers. aInadequate supply: cases where participants were supplied with pills
not covering the period up to next visit. SD standard deviation
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Discussion
Our results showed that the overall good consumption
of IFA supplements throughout pregnancy in Eswatini
was approximately 7 and 8 % for iron and folic acid sup-
plements, respectively. The overall adherence rate to
iron supplementation across 22 Sub-Saharan African
(SSA) countries (excluding Eswatini) was 28.7 % and
ranged from 1.4 % in Burundi to 73.0 % in Senegal [14].
This consumption pattern is still relatively low than that
in other countries, such as South Africa, where compli-
ance with the consumption of IFA supplements was re-
ported to be 93 % among pregnant women [26]. Another
African country with a higher consumption rate is
Kenya, with compliance to IFA at approximately 80 %
[23]. The adherence to IFA supplementation was 28.7 %
in Ethiopia [24], which was similar to this study in which
Table 4 Distribution of participants’ responses about knowledge (N = 330)
Total Iron consumption Folate consumption
Variables n (%) Good (n = 22) Poor (n = 308) Good (n = 26) Poor (n = 304)
A list of three food items that are a good source of iron.
All three responses correct 91 (27.6) 10 (45.5) 81 (26.3) 11 (42.3) 80 (26.3)
Only two correct responses 112 (33.9) 9 (40.9) 103 (33.4) 10 (38.5) 102 (33.6)
Only one correct response 91 (27.6) 2 (9.1) 89 (28.9) 4 (15.4) 87 (28.6)
No correct response 36 (10.9) 1 (4.5) 35 (11.4) 1 (3.8) 35 (11.5)
A list of three food items that are a good source of folate.
All three responses correct 36 (10.9) 4 (18.2) 32 (10.4) 5 (19.2) 31 (10.2)
Only two correct responses 43 (13.0) 3 (13.6) 40 (13.0) 4 (15.4) 39 (12.8)
Only one correct response 186 (56.4) 11 (50.0) 175 (56.8) 13 (50.0) 173 (56.9)
No correct response 65 (19.7) 4 (18.2) 61 (19.8) 4 (15.4) 61 (20.1)
When should a pregnant woman start consuming IFA supplements?
Correct response 118 (35.8) 16 (72.7) 102 (33.1) 18 (69.2) 100 (67.1)
Incorrect response 212 (64.2) 6 (27.3) 206 (66.9) 8 (30.8) 204 (32.9)
A list of three benefits of consuming IFA supplements during pregnancy.
All three responses correct 34 (10.3) 9 (40.9) 25 (8.1) 8 (30.8) 26 (8.6)
Only two correct responses 92 (27.9) 5 (22.7) 87 (28.2) 9 (34.6) 83 (27.3)
Only one correct response 146 (44.2) 6 (27.3) 140 (45.5) 7 (26.9) 139 (45.7)
No correct response 58 (17.6) 2 (9.1) 56 (18.2) 2 (7.7) 56 (18.4)
A list of three consequences of not consuming IFA supplements during pregnancy
All three responses correct 19 (5.8) 8 (36.4) 11 (3.6) 7 (26.9) 12 (3.9)
Only two responses correct 52 (15.8) 6 (27.3) 46 (14.9) 7 (26.9) 45 (14.8)
Only one correct response 185 (56.1) 7 (31.8) 178 (57.8) 11 (42.3) 174 (57.2)
No correct response 74 (22.4) 1 (4.5) 73 (23.7) 1 (3.8) 73 (24.0)
Knowledge scores; Mean (SD) 5.65 (2.91)
Score range: 1–13. A higher score indicates better knowledge. IFA iron and folic acid supplements; SD standard deviation
Table 5 Distribution of participants’ responses about attitude (N = 330)
Attitudes Strongly agree Agree Not sure Disagree Strongly disagree
n (%) n (%) n (%) n (%) n (%)
IFA is good for fetus 134 (40.6) 179 (54.2) 17 (5.2) 0 (0.0) 0 (0.0)
Pregnant women should adhere to IFA 122 (37.0) 112 (33.9) 90 (27.3) 6 (1.8) 0 (0.0)
Consuming IFA could result in fetal macrosomia 85 (25.8) 57 (17.3) 94 (28.5) 28 (8.5) 66 (20.0)
IFA could result in unsuccessful pregnancies 4 (1.2) 4 (1.2) 73 (22.1) 74 (22.4) 175 (53.0)
IFA should be taken only when there is a problem 6 (1.8) 24 (7.3) 92 (27.9) 105 (31.8) 103 (31.2)
Attitudes’ sum of score; Mean (SD) 19.29 (3.16)
Score range: 0–25. A higher total score indicates more positive attitude towards IFA supplementation. IFA iron and folic acid; SD standard deviation
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the consumption was < 50 %. It was noted that the num-
bers might not be directly comparable since the meas-
urement of adherence or good consumption varied
across studies. Nonetheless, IFA supplementation for
pregnant women in Eswatini needs to be further
advocated.
Despite the low rate of good consumption of IFA sup-
plementation throughout all trimesters of pregnancy, we
found that the rate of good consumption increased from
10 % in the first trimester to approximately 40 % in the
second and third trimesters. The low rate of good con-
sumption of IFA supplements throughout pregnancy
was mainly owing to late ANC booking, and thus, late
commencement of IFA consumption since only 23 % of
the participants booked ANC within their first trimester.
It was noted that approximately 14 and 5 % of partici-
pants did not adhere to the consumption of IFA supple-
ments in the second and third trimester, respectively,
because they did not attend ANC or did not receive the
supply in facilities due to limited stock. IFA consump-
tion increased to 46 % in our participants during the sec-
ond and third trimesters after those who did not receive
IFA were excluded (data not shown). Thus, ANC in the
first trimester should be emphasized, and supplies of
IFA supplements in facilities should be better managed.
Participants’ age was found to be associated with iron
consumption in our study, which is consistent with
other studies [14, 26]. Ba and colleagues suggested that
the positive association between age and adherence to
iron supplementation during pregnancy could be ex-
plained by older women’s understanding of the benefits
of iron supplementation for preventing anemia or having
previously experienced iron deficiency-related adverse
outcomes [14].
A positive association was observed between positive
attitudes and consumption of IFA in our study. Strong
agreement that IFA supplementation is good for the
fetus was observed in 40.6 % of the participants, whereas
negative attitude, such as strong agreement that IFA
supplementation results in fetal macrosomia, was ob-
served in 25.8 % of the study participants. Similarly, the
beliefs that the supplement tablets would harm the baby
were found to be significantly associated with non-
compliance to IFA consumption in the Mecha district,
Ethiopia [27]. The major barrier, associated with the
lower consumption of IFA supplements, was the side ef-
fects, which was also listed in other studies as a major
obstacle for the consumption and compliance [28, 29].
Therefore, it is recommended that healthcare workers in
the facilities correct misconceptions about IFA con-
sumption and instruct women on how to manage the
potential side effects of IFA supplementation.
In our study, knowledge of IFA supplements was sig-
nificantly associated with the consumption of folic acid
supplements in the second and third trimesters. A simi-
lar finding was observed in Kenya, where the authors
concluded that knowledge of IFA among pregnant
women was associated with improved compliance [30].
Knowledge was significantly associated with compliance
to prenatal IFA supplementation among women in
Mecha, Ethiopia [27]. In another study in Northwest
Ethiopia, knowledge about the benefits of supplements
was associated with IFA supplementation adherence
among pregnant women [31]. Based on the previous lit-
erature and our findings, we assume that informed preg-
nant women are more likely to consume adequate
supplementation because they have been empowered,
and they understand the benefits that come with
supplementation.
Our study results should be acknowledged within the
following limitations. The selection bias was possible,
since the study participants were pregnant women at-
tending antenatal care at eight healthcare facilities,
which is not a random sample of pregnant women and
may not represent pregnant women in Eswatini. Those
women who used antenatal care may be more likely to
take IFA than those who did not. Owing to the cross-
sectional nature of the study, the associated factors were
correlational rather than causal. The exclusion of women
aged < 18 years limited the generalizability of our find-
ings to all pregnant women and prevented the identifica-
tion of factors that may be unique to this age group.
Table 6 Logistic regression models of factors associated with good IFA consumption during pregnancy (N = 330)
Good iron consumption Good folic acid consumption
Explanatory variables AOR 95% CI p-value AOR 95% CI p-value
Age NS
18–24 1.00
25–30 2.92 (0.71–12.06) 0.14
31 and above 4.44 (1.09–18.10) 0.04*
Knowledge 1.23 (1.05–1.44) 0.001* 1.24 (1.07–1.43) 0.004*
Attitude 1.41 (1.13–1.75) < 0.002* NS
Barriers 0.53 (0.29–0.97) 0.04* 0.51 (0.31–0.89) 0.02*
NS not statistically significant and was not included in the model; IFA iron and folic acid; AOR adjusted odds ratio; CI confidence interval. *P < 0.05
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However, these factors may be crucial when developing
strategies to improve the consumption of IFA by all
pregnant women. There is a possibility of recall bias
since participants were asked about their consumption
patterns from the first trimester to the third trimester.
There is also a possibility that some of the participants
were reporting what they deemed socially acceptable
and reporting about pills that they did not ingest.
Conclusions
In summary, IFA supplement consumption among preg-
nant women is poor in Eswatini, despite IFA supplemen-
tation being included as part of the ANC package. It is
evident that most women still lack knowledge, and some
have negative attitudes regarding IFA supplements. The
findings show that side effects, forgetfulness, safe previ-
ous pregnancies without IFA, others’ advice against con-
sumption, IFA stock-outs, inability to meet transport
costs, and inadequate supply of IFA tablets are barriers
to adherence to IFA supplement consumption. To im-
prove consumption, strategies such as establishing a pre-
conception care unit and school-based provision of IFA
supplements may be helpful. Multiple strategies need to
be employed to overcome the identified barriers. These
strategies may include community health care workers
for distributing IFA supplements, discussing with clients
about the measures to reduce forgetfulness, advising
ways to prevent and manage the side effects, providing
subsidies to cover transport costs, and ensuring adequate
supply of IFA supplements in facilities. To address the
negative attitudes and lack of knowledge, known accur-
ate information should be revisited and reinforced in
health education, myths should be dispelled, and the im-
portance of IFA supplementation should be intensified.
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